Posos Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 13

Posos General Information

Description

Developer of clinical decision support software designed to analyze medication-related data within healthcare workflows. The company's platform offers tools such as medication analysis tools, prescribing decision support, drug information databases, clinical data integration, and reporting functionalities, enabling healthcare professionals to access structured medication insights.

Contact Information

Website
www.posos.co
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Amiens Le Lab
  • 60 rue de la Vallée
  • 80000 Amiens
  • France
+33 03
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Digital Health, Artificial Intelligence & Machine Learning, HealthTech, Mobile
Corporate Office
  • Amiens Le Lab
  • 60 rue de la Vallée
  • 80000 Amiens
  • France
+33 03

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Posos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
7. Later Stage VC (Series A) 07-Oct-2022 Completed Generating Revenue
6. Accelerator/Incubator 30-Jun-2020 Completed Product In Beta Test
5. Accelerator/Incubator 06-May-2020 Completed Product In Beta Test
4. Equity Crowdfunding 15-Oct-2019 Completed Product In Beta Test
3. Early Stage VC 31-Jul-2019 Completed Startup
2. Angel (individual) 04-May-2018 $147K $147K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Posos’s complete valuation and funding history, request access »

Posos Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Category S
Ordinary
To view Posos’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Posos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of clinical decision support software designed to analyze medication-related data within healthcare workflows.
Decision/Risk Analysis
Amiens, France
40 As of 2025

Paris, France
 

Bordeaux, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Posos Competitors (3)

One of Posos’s 3 competitors is PharmIA (Other Healthcare Technology), a Corporation company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PharmIA (Other Healthcare Technology) Corporation Paris, France
Synapse Global Venture Capital-Backed Bordeaux, France
Bimedoc Accelerator/Incubator Backed Lyon, France
You’re viewing 3 of 3 competitors. Get the full list »

Posos Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Posos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4172996-A1 Pharmacological recommendation system Inactive 26-Jun-2020
FR-3112019-A1 Pharmacological recommendation system Inactive 26-Jun-2020
US-20240079109-A1 Pharmacological recommendation system Pending 26-Jun-2020
WO-2021260333-A1 Pharmacological recommendation system Inactive 26-Jun-2020 G16H20/10

Posos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Posos Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Caelestinus Accelerator/Incubator
AG2R La Mondiale Limited Partner Minority
Avolta Partners PE-Backed Company Minority
Caisse des Depots Group Sovereign Wealth Fund Minority
Clubster NHL Corporation Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

Posos FAQs

  • When was Posos founded?

    Posos was founded in 2017.

  • Where is Posos headquartered?

    Posos is headquartered in Amiens, France.

  • What is the size of Posos?

    Posos has 40 total employees.

  • What industry is Posos in?

    Posos’s primary industry is Decision/Risk Analysis.

  • Is Posos a private or public company?

    Posos is a Private company.

  • What is Posos’s current revenue?

    The current revenue for Posos is .

  • How much funding has Posos raised over time?

    Posos has raised $13.2M.

  • Who are Posos’s investors?

    Caelestinus, AG2R La Mondiale, Avolta Partners, Caisse des Depots Group, and Clubster NHL are 5 of 13 investors who have invested in Posos.

  • Who are Posos’s competitors?

    PharmIA (Other Healthcare Technology), Synapse Global, and Bimedoc are competitors of Posos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process